 effect enteric-coated aspirin morning increase platelet activity vitro platelet aggregability diphosphate ADP epinephrine increases morning frequency myocardial infarction single-blind cross-over study healthy males measures platelet activity morning increases aspirin increases platelet activity Subjects mg enteric-coated aspirin ECA placebo placebo therapy platelet thromboxane production collagen stimulation subjects aggregability ADP epinephrine collagen ECA baseline platelet thromboxane production increase subjects biphasic aggregation response ADP morning increase aggregability agents collagen lag time synergistic aggregation agonists effective day increases tissue plasminogen activator subjects arising aspirin prevents myocardial infarction antiplatelet action likely preferential reduction morning infarction Health Study demonstration aspirin morning increase platelet activity morning increase myocardial infarction due part concurrent modest increase platelet activity